logo

Monopar Therapeutics Inc (MNPR) Stock: Navigating Drops and Gains

PNC Stock

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Monopar Therapeutics Inc’s current trading price is -74.54% away from its 52-week high, while its distance from the 52-week low is 177.98%. The stock’s price range during this period has varied between $0.27 and $2.99. The company, active in the Healthcare sector, saw a trading volume of around 0.95 million for the day, considerably lower average daily volume of 5.54 million observed over the last three months.

The market performance of Monopar Therapeutics Inc has been somewhat unstable. Over the past year, the company’s stock achieved a high of $2.99 on 03/24/23, with the lowest value for the same timeframe being $0.27, recorded on 11/27/23.

How Financial Performance Impacts Market Capitalization

Monopar Therapeutics Inc (MNPR) has experienced a quarterly rise of 106.51% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 11.32M and boasts a workforce of 12 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.4827, with a change in price of +0.2948. Similarly, Monopar Therapeutics Inc recorded 4,049,695 in trading volume during the last 100 days, posting a change of +63.18%.

How MNPR’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for MNPR stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

MNPR Stock Stochastic Average

As of today, the raw stochastic average of Monopar Therapeutics Inc over the past 50 days is 31.84%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 20.61%. Additionally, the Stochastic %K and %D values for the company were 18.70% and 21.99%, respectively, over the past 20 days.

MNPR Stock Price Performance Analysis

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The metric has seen a significant gain of 123.81% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 28.61%. Over the past 30 days, the price of MNPR has fallen by 122.24%. And in the last five days, it has fallen by -7.82%.